The world’s energy demand is rising, and NREL’s ULIS power module could help meet it. Demand for energy worldwide is climbing rapidly, driven in part by power hungry data centers that support ...

'Mad Money' host Jim Cramer weighs in on stocks including: Recursion Pharmaceuticals and NuScale Power. White House responds to Pope Leo’s rebuke of Trump peace plan for Ukraine After winning his ...

If only they were robotic! Instead, chatbots have developed a distinctive — and grating — voice. Credit...Illustration by Giacomo Gambineri Supported by By Sam Kriss In the quiet hum of our digital ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

A growing number of special education teachers say they use artificial intelligence platforms to draft all or part of students’ individualized education programs, even as many districts lack policies ...

GARDEN CITY, Long Island (WABC) -- A college student on Long Island says he was wrongly accused of using artificial intelligence to write an essay, and now he's suing his university. Adelphi ...

Recursion Pharmaceuticals uses AI to expedite the laborious process of developing drugs. The company could benefit from industry-wide regulatory changes as well as its own clinical progress. However, ...

Apple Inc. is in early discussions about using Google Gemini to power a revamped version of the Siri voice assistant, marking a key potential step toward outsourcing more of its artificial ...

I used to believe I taught the one genre that artificial intelligence couldn’t touch. For 15 years, I’ve guided college students through the deeply human work of personal narrative, helping them ...